{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-025291","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.380266+00:00","generated_at":"2026-06-28T12:47:26.828560+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Puma Biotechnology Q3 net loss widens to $44.7M; product revenue falls 12%","bullets":["Q3 product revenue $43.4M, down from $49.3M YoY; COVID-19 impact and inventory reduction of ~$3.5M.","GAAP net loss $44.7M ($1.09/share) vs $31.5M ($0.79/share) in Q3 2020; non-GAAP adj. loss $40.4M.","Cash, cash equivalents, and marketable securities $87.5M at Sep 30; operating cash flow $10.5M positive.","Nine-month 2021 total revenue $197.8M included $50M upfront from Pierre Fabre for Greater China rights.","Milestones: SUMMIT trial data, FDA Type C meeting for accelerated approval in HER2-mutated breast cancer, regulatory decisions."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-025291","json":"https://secwatch.observer/filing/0001437749-21-025291.json","markdown":"https://secwatch.observer/filing/0001437749-21-025291.md","text":"https://secwatch.observer/filing/0001437749-21-025291.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774921025291/0001437749-21-025291-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774921025291/pbyi20211103_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T12:47:26.828560+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}